Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
Clinical trial NCT00390611 · COMPLETED
Trial details
- NCT number
- NCT00390611
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2012-07-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.